| Bruce Rothschild, M.d., Pllc | |
|
34 Jerome Ave Bloomfield CT 06002-2463 | |
| (860) 243-5024 | |
| (860) 286-9948 |
| Full Name | Bruce Rothschild, M.d., Pllc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 34 Jerome Ave, Bloomfield, Connecticut |
| Authorized Official Name and Position | Bruce Stephen Rothschild (MEMBER) |
| Authorized Official Contact | 8608103805 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Bruce Rothschild, M.d., Pllc 34 Jerome Ave Bloomfield CT 06002-2463 Ph: (860) 243-5024 | Bruce Rothschild, M.d., Pllc 34 Jerome Ave Bloomfield CT 06002-2463 Ph: (860) 243-5024 |
| NPI Number | 1043719776 |
|---|---|
| Provider Enumeration Date | 02/08/2018 |
| Last Update Date | 02/08/2018 |
| Medicare PECOS PAC ID | 2769744333 |
|---|---|
| Medicare Enrollment ID | O20180319001633 |
News Archive
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
This week's issue of the Lancet "has an HIV theme ahead of the International AIDS Society meeting in Washington, D.C., ... on July 22-27," a Lancet editorial states, noting, "The issue of antiretrovirals for prevention, specifically pre-exposure prophylaxis, is presently under intense debate."
President Obama is pressing the Senate to pass health care legislation as soon as possible. "The White House, growing concerned that the Congressional timetable for passing a health care overhaul could slip into next year, is stepping up pressure on the Senate for quick action, with President Obama appearing Sunday in the Rose Garden to call on senators to 'take up the baton and bring this effort to the finish line,'" The New York Times reports.
Actavis, Inc. today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Propofol Injection 10mg/mL.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043719776 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 029851 (Connecticut) | Primary |
| Provider Name | Bruce S Rothschild |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1407821176 PECOS PAC ID: 4981743184 Enrollment ID: I20091201000522 |
News Archive
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
This week's issue of the Lancet "has an HIV theme ahead of the International AIDS Society meeting in Washington, D.C., ... on July 22-27," a Lancet editorial states, noting, "The issue of antiretrovirals for prevention, specifically pre-exposure prophylaxis, is presently under intense debate."
President Obama is pressing the Senate to pass health care legislation as soon as possible. "The White House, growing concerned that the Congressional timetable for passing a health care overhaul could slip into next year, is stepping up pressure on the Senate for quick action, with President Obama appearing Sunday in the Rose Garden to call on senators to 'take up the baton and bring this effort to the finish line,'" The New York Times reports.
Actavis, Inc. today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Propofol Injection 10mg/mL.
› Verified 2 days ago
| Provider Name | Zoey Walker |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1841761731 PECOS PAC ID: 0446598825 Enrollment ID: I20190208003092 |
News Archive
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
This week's issue of the Lancet "has an HIV theme ahead of the International AIDS Society meeting in Washington, D.C., ... on July 22-27," a Lancet editorial states, noting, "The issue of antiretrovirals for prevention, specifically pre-exposure prophylaxis, is presently under intense debate."
President Obama is pressing the Senate to pass health care legislation as soon as possible. "The White House, growing concerned that the Congressional timetable for passing a health care overhaul could slip into next year, is stepping up pressure on the Senate for quick action, with President Obama appearing Sunday in the Rose Garden to call on senators to 'take up the baton and bring this effort to the finish line,'" The New York Times reports.
Actavis, Inc. today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Propofol Injection 10mg/mL.
› Verified 2 days ago
News Archive
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
This week's issue of the Lancet "has an HIV theme ahead of the International AIDS Society meeting in Washington, D.C., ... on July 22-27," a Lancet editorial states, noting, "The issue of antiretrovirals for prevention, specifically pre-exposure prophylaxis, is presently under intense debate."
President Obama is pressing the Senate to pass health care legislation as soon as possible. "The White House, growing concerned that the Congressional timetable for passing a health care overhaul could slip into next year, is stepping up pressure on the Senate for quick action, with President Obama appearing Sunday in the Rose Garden to call on senators to 'take up the baton and bring this effort to the finish line,'" The New York Times reports.
Actavis, Inc. today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Propofol Injection 10mg/mL.
› Verified 2 days ago
Bonnie K. Scranton Msw Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 45 Wintonbury Ave, Suite 318, Bloomfield, CT 06002 Phone: 860-878-8142 Fax: 860-242-1476 | |
Connecticut Neurology Consultants Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 580 Cottage Grove Rd, #106, Bloomfield, CT 06002 Phone: 860-243-9709 Fax: 860-243-2522 | |
Judith G. Hunt, Lmft, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 11 Mountain Ave, Suite 204, Bloomfield, CT 06002 Phone: 860-286-0528 Fax: 860-286-0585 | |
Children 1st Counseling Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3 Barnard Lane, Bloomfield, CT 06002 Phone: 860-916-6996 Fax: 860-726-9191 | |
Ebb And Flow Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 701 Cottage Grove Rd Ste E230, Bloomfield, CT 06002 Phone: 860-351-3072 | |
Reflections Psychotherapy Services Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 701 Cottage Grove Rd, Suite F 120, Bloomfield, CT 06002 Phone: 860-878-9145 Fax: 860-242-7811 |